| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1742-7843.2010.00642.X |
| P953 | full work available at URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2010.00642.x |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-7843.2010.00642.x | ||
| P698 | PubMed publication ID | 21073659 |
| P5875 | ResearchGate publication ID | 47789097 |
| P2093 | author name string | Hong Shen | |
| Xiaobo Li | |||
| Hong Xiao | |||
| Haiqing Zhu | |||
| Hongyi Liu | |||
| Zhuo Wu | |||
| Yanyan Zeng | |||
| Xiaoming Zhuang | |||
| P2860 | cites work | Efficient delivery of siRNA for inhibition of gene expression in postnatal mice | Q74531314 |
| Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation | Q82926359 | ||
| RNA interference is mediated by 21- and 22-nucleotide RNAs | Q27860764 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs | Q28251399 | ||
| Gene therapy progress and prospects: electroporation and other physical methods. | Q31104973 | ||
| Electrochemotherapy in treatment of tumours. | Q34004997 | ||
| Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection | Q34161732 | ||
| A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. | Q34762243 | ||
| Gene silencing in mammals by small interfering RNAs | Q34931992 | ||
| High-efficiency gene transfer into skeletal muscle mediated by electric pulses | Q35123357 | ||
| Electroporation gene therapy: new developments in vivo and in vitro | Q35895814 | ||
| RNA interference and the use of small interfering RNA to study gene function in mammalian systems | Q35980334 | ||
| Electroporation for targeted gene transfer | Q36316716 | ||
| Prospects of RNA interference therapy for cancer | Q36337922 | ||
| The silent treatment: siRNAs as small molecule drugs | Q36362370 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| RNAi therapeutics: a potential new class of pharmaceutical drugs | Q36654918 | ||
| RNA interference: implications for cancer treatment | Q36738853 | ||
| In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi | Q39932818 | ||
| In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency | Q40023989 | ||
| A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics | Q40554467 | ||
| Long-lasting RNAi activity in mammalian neurons | Q40593615 | ||
| Modulation of HIV-1 replication by RNA interference | Q40721798 | ||
| siRNA-directed inhibition of HIV-1 infection | Q40727988 | ||
| Knocking down disease with siRNAs | Q45032111 | ||
| In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. | Q45866535 | ||
| In vivo electrically mediated protein and gene transfer in murine melanoma | Q74259487 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | RNA interference | Q201993 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 177-184 | |
| P577 | publication date | 2010-11-12 | |
| P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
| P1476 | title | In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA | |
| P478 | volume | 108 |
| Q39042837 | Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier |
| Q38920285 | FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein |
| Q42016539 | In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs. |
| Q41836725 | Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance |
| Q38330317 | MRP1 expressed on Burkitt's lymphoma cells was depleted by catfish egg lectin through Gb3-glycosphingolipid and enhanced cytotoxic effect of drugs |
| Q38901160 | Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1. |
Search more.